Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-24-019472)

Filing Details

Accession Number:: 0001415889-24-019472
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-07-10 17:34:39
Reporting Period:: 2024-07-08

Accepted Time:: 2024-07-10 17:34:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1679363	Morphic Holding Inc.	MORF	Pharmaceutical Preparations (2834)	473878772

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1773184	Marc Schegerin	C/O Morphic Holding, Inc. 35 Gatehouse Drive, A2 Waltham MA 02451	Cfo And Coo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-07-08	43,936	$15.00	81,843	No	4	M	Direct
Common Stock	Disposition	2024-07-08	43,936	$55.80	37,907	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2024-07-08	43,936	$0.00	43,936	$15.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
13,332		2030-04-05	No	4	M	Direct

Footnotes

Includes 447 shares of Common Stock acquired under the issuer's employee stock purchase plan on February 29, 2024.
The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024.
The option is fully vested.